All Posts By

Smartkarma Daily Briefs

Daily Brief Health Care: Amvis Holdings Inc, Torii Pharmaceutical, Luye Pharma, Mannkind Corp, Oryzon Genomics, Respiri Ltd and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Amvis Holdings Placement – Has Done Exceptionally Well, Now It’s Prime Time
  • Torii Pharmaceutical (4551 JP): Board Opposes Shareholder Proposal for Appropriation of Surplus
  • Luye Pharma Placement (2186.HK) – The Potential Downside to Valuations Is Large
  • Mannkind Corp (MNKD US): Stable Revenue Stream; High Hope for MNKD 101 for Rare Lung Disease
  • Oryzon Genomics – Progress in oncology and CNS in FY22
  • Respiri – wheezo included in paediatric standard of care

Amvis Holdings Placement – Has Done Exceptionally Well, Now It’s Prime Time

By Sumeet Singh

  • Amvis Holdings Inc (7071 JP) (AH)’s founder aims to raise around US$250m via a secondary follow-on offering.
  • The deal will increase the free-float of the stock and will lead to the stock being transferred to the Prime segment.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Torii Pharmaceutical (4551 JP): Board Opposes Shareholder Proposal for Appropriation of Surplus

By Tina Banerjee

  • LIM Japan Event Master Fund sent a document to Torii Pharmaceutical (4551 JP) requesting the company to distribute 100% of its surplus to shareholders and conduct a drastic share buyback.
  • LIM is of view that Torii has excess cash balances, which is more than the market cap of the company. Inefficient use of capital has led to low single-digit ROE.
  • Torii opposes the proposal, as the company thinks it needs adequate cash to pursue business development aka in-licensing of new drugs.  

Luye Pharma Placement (2186.HK) – The Potential Downside to Valuations Is Large

By Xinyao (Criss) Wang

  • The decline in revenue from multiple categories of drugs due to VBP indicates that Luye Pharma (2186 HK) urgently needs a group of new products to reverse the overall weak performance. 
  • Without the advantages in R&D efficacy and product competitiveness, the current pipeline would generate little value. It’s hard to convince people that the fundamentals of Luye have truly changed.
  • We are not optimistic about Luye’s outlook, which lacks long investment logic. Meanwhile, we think that this Placement is not cost-effective due to more potential downside to valuation.

Mannkind Corp (MNKD US): Stable Revenue Stream; High Hope for MNKD 101 for Rare Lung Disease

By Tina Banerjee

  • Mannkind Corp (MNKD US) has multiple revenue stream, with two marketed products. Flagship drug Afrezza, an inhaled insulin recorded 11% YoY revenue growth to $10.8M in Q3.
  • Due to high R&D and SG&A expenses, Mannkind records operating loss. However, gross profit margin is improving, with Afrezza gross margin improving to 81% in 3Q22 from 61% in 3Q21.
  • Mannkind’s inhaled clofazimine (MNKD 101) is advancing to Phase 2/3 study for potential treatment of nontuberculous mycobacterial (NTM) lung disease. ~86K people in US are living with NTM lung disease.

Oryzon Genomics – Progress in oncology and CNS in FY22

By Edison Investment Research

Oryzon Genomics has presented headline FY22 financial results, which reflect continued progress on its clinical activities for key assets iadademstat (oncology) and vafidemstat (central nervous system; CNS) across different programmes. Total operating expenses for the year were US$22.9m, up by 13.5% from US$20.2m in FY21 and slightly higher than our estimate of US$20.1m. As expected, the bulk of these costs (c 80%) related to R&D expenses (US$18.1m) as the company continues to focus on advancing its clinical pipeline. The period-end gross cash balance was US$22.7m, which at historical burn rates (€6.92m/US$7.3m in H122) should fund the company into H225, past key clinical readouts. Looking ahead, we see the start of patient enrolment in the FRIDA study for relapsed/refractory (r/r) FLT3+ acute myeloid leukaemia (AML) patients and top-line data from the PORTICO study for borderline personality (BPD) disorder in Q123 as key upcoming catalysts.


Respiri – wheezo included in paediatric standard of care

By Edison Investment Research

Respiri has announced the successful completion of the Michigan Children’s Hospital’s pilot programme assessing the wheezo SAAS (Respiri and partner Access Telehealth) platform. The initial March 2022 agreement enabled pulmonologists to employ wheezo to increase the engagement of paediatric patients with asthma. The hospital will include the wheezo RPM programme in its current standard of care for eligible asthma patients. We expect the paediatric population to be one of the cohorts to find the most utility from the wheezo monitoring protocol (given this population is not always able to self-identify and flag symptoms) and usage feedback from these patients is anticipated to be crucial for Respiri. We also note the Michigan Children’s Hospital is a part of the of the NYSE-listed Tenet Healthcare Corporation (over 60 hospitals across the US) and uptake, if encouraging, can support a broader roll out.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Industrials: Jiangnan, Walsin Lihwa, TVS Supply Chain Solutions, Alfen and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Jiangnan Group (1366 HK): Chairman/CEO’s Privatisation Offer at HK$0.40
  • Quiddity TWSE 50 & 100 Mar 23 Final Expectations: There Could Be a Surprise Index Change!
  • TVS Supply Chain Solutions Pre-IPO – Profitability Might Have Been COVID-Driven
  • Quiddity Leaderboard SE600 Mar 23: Linde Deletion and 6 Regular ADDs/DELs
  • This Is Done. Chu’s Offer For Jiangnan (1366 HK)

Jiangnan Group (1366 HK): Chairman/CEO’s Privatisation Offer at HK$0.40

By Arun George

  • Jiangnan (1366 HK) disclosed a scheme privatisation offer from Mr Chu Hui (Chairman and CEO) at HK$0.40 per share, a 107.3% premium to the undisturbed price (HK$0.193 on 13 February).
  • The key condition is approval by at least 75% of disinterested shareholders (<10% of all disinterested shareholders rejection). The shareholder with a blocking stake will be supportive. 
  • The price is final and attractive in the context of historical prices and multiples. The scheme meeting is likely in mid-May. At last close, the gross spread is 12.7%.

Quiddity TWSE 50 & 100 Mar 23 Final Expectations: There Could Be a Surprise Index Change!

By Janaghan Jeyakumar, CFA

  • The reference period for the March 2023 index review for TWSE 50 and 100 indices just came to an end on 20 February.
  • Previously, it looked like there would not be any index changes during the March 2023 review for these two indices.
  • However, now it looks like there could be a change. 

TVS Supply Chain Solutions Pre-IPO – Profitability Might Have Been COVID-Driven

By Ethan Aw

  • TVS Supply Chain Solutions (1915741D IN) is looking to raise about US$500m in its upcoming India IPO.
  • TVS SCS is an Indian supply chain logistics solution provider which also has global capabilities and network across the value chain with cross deployment abilities, according to RedSeer. 
  • TVS SCS has seen its revenue grow as both its operating segments registered decent growth during the track record period. However, its profitability might have been a result of COVID-19. 

Quiddity Leaderboard SE600 Mar 23: Linde Deletion and 6 Regular ADDs/DELs

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the names leading the race to become ADDs/DELs for the STOXX Europe 600 and EURO STOXX Indices for the March 2023 Rebalance.
  • As it stands, I see 6 ADDs/DELs for the STOXX Europe 600 index and 3 ADDs and 2 DELs for the Euro STOXX Index in March 2023.
  • There are several names requiring a small price change to trigger more constituent changes and with few more days left to the reference date, a lot can change.

This Is Done. Chu’s Offer For Jiangnan (1366 HK)

By David Blennerhassett

  • After shares gained 63% in the morning session of the 16 Feb, then subsequently suspended, Chu Hui, the chairman and major shareholder, has made his move on Jiangnan (1366 HK).
  • Chu is offering HK$0.40/share by of a Scheme, a 12.68% premium to last close, but a whopping 83.49% over the last full trading day’s closing price. This price is final.
  • This is done. Expect payment around late July based on precedent Cayman-incorporated privatisations. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Most Read: Sembcorp Marine, Ecopro Co Ltd, Amvis Holdings Inc, Fujitec Co Ltd, SK Telecom, Jiangnan, DGB Financial Group, Pushpay Holdings, Nitro Software Ltd and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Sembcorp Marine (SMM SP): MSCI Inclusion Confirmed as Shorts Surge
  • Sembcorp Marine (SMM SP) – MSCI Pulls a Surprise Late Inclusion – All Engines Reverse Full!
  • Ecopro Co: Shorting Entry Points on CB Conversion Event
  • Amvis Holdings Placement – Has Done Exceptionally Well, Now It’s Prime Time
  • Fujitec EGM Coming 24 Feb – It’s a Close-Run Thing
  • Foreign Room Race for MSCI Re-Inclusion: SK Telecom Is Unexpectedly Rising
  • Jiangnan Group (1366 HK): Chairman/CEO’s Privatisation Offer at HK$0.40
  • KOSPI200 Index Rebalance Preview: Changes in April & June
  • Pushpay Holdings: ACC & Nikko Say No To Scheme
  • Nitro Software: KKR’s Offer Unconditional. This Is Potentia’s For The Taking

Sembcorp Marine (SMM SP): MSCI Inclusion Confirmed as Shorts Surge

By Brian Freitas


Sembcorp Marine (SMM SP) – MSCI Pulls a Surprise Late Inclusion – All Engines Reverse Full!

By Travis Lundy

  • Last night, MSCI announced Sembcorp Marine (SMM SP) will be added to MSCI Standard effective 2 March as the KOM Consideration Shares become tradable. This is something of a surprise.
  • That other index family announced a temp line would be added to the index on receipt by Keppel shareholders. This dramatically changes the Day1 overhang arithmetic. 
  • It erases most but not all of the Day 1 passive overhang, and means adding shares for the existing SMM portion. Medium-long-term active overhang is unchanged.

Ecopro Co: Shorting Entry Points on CB Conversion Event

By Sanghyun Park

  • For the recent conversion, the listing date is March 3rd, involving 500K shares. Despite the ongoing rally, there is a possibility of a significant price impact due to the volume.
  • We still have 1,632,333 shares to be converted. This represents 6.5% of the SO. There is a high likelihood that these will also be applied for conversion soon.
  • Assuming that it occurs in increments of 400-500K, there could be roughly 3-4 opportunities for shorting.

Amvis Holdings Placement – Has Done Exceptionally Well, Now It’s Prime Time

By Sumeet Singh

  • Amvis Holdings Inc (7071 JP) (AH)’s founder aims to raise around US$250m via a secondary follow-on offering.
  • The deal will increase the free-float of the stock and will lead to the stock being transferred to the Prime segment.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Fujitec EGM Coming 24 Feb – It’s a Close-Run Thing

By Travis Lundy


Foreign Room Race for MSCI Re-Inclusion: SK Telecom Is Unexpectedly Rising

By Sanghyun Park

  • Looking at the recent pattern, SKT’s fast-rising is quite noticeable. Its foreign room rose to 12.08%. On the other hand, KT’s foreign room growth seems to be slowing somewhat.
  • SKT’s pace is fast. If the current pace continues, there will be even the possibility of inclusion with a full adjustment factor of 1.0, exceeding 25%, by the August review. 
  • We should design a momentum trading setup targeting the point when SKT’s foreign room decline trend will be reflected into an MSCI re-inclusion momentum.

Jiangnan Group (1366 HK): Chairman/CEO’s Privatisation Offer at HK$0.40

By Arun George

  • Jiangnan (1366 HK) disclosed a scheme privatisation offer from Mr Chu Hui (Chairman and CEO) at HK$0.40 per share, a 107.3% premium to the undisturbed price (HK$0.193 on 13 February).
  • The key condition is approval by at least 75% of disinterested shareholders (<10% of all disinterested shareholders rejection). The shareholder with a blocking stake will be supportive. 
  • The price is final and attractive in the context of historical prices and multiples. The scheme meeting is likely in mid-May. At last close, the gross spread is 12.7%.

KOSPI200 Index Rebalance Preview: Changes in April & June

By Brian Freitas


Pushpay Holdings: ACC & Nikko Say No To Scheme

By David Blennerhassett

  • The Scheme Meeting for BGH/Sixth Street’s NZ$1.34/share Offer for church donor management play Pushpay Holdings (PPH NZ) will take place on the 3 March.
  • Accident Compensation Corporation (ACC), holding 6.2% of shares out, said it will vote against the Scheme. Nikko Asset Management (1.4%) also said they will reject the Offer. 
  • Shares have wobbled and are now 5.5% adrift of terms. BGH/Sixth Street still has the flexibility to bump.

Nitro Software: KKR’s Offer Unconditional. This Is Potentia’s For The Taking

By David Blennerhassett

  • Alludo has declared its Offer of A$2.15 cash per Nitro Software Ltd (NTO AU) share free from all remaining conditions.
  • Separately, Potentia’s due diligence is expected to conclude tomorrow, the 22 February, with the expectation it bumps its current offer of A$2.00/share.
  • Currently trading at A$2.20 per share suggesting limited upside from here. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief TMT/Internet: SK Telecom, Alibaba (ADR), Pushpay Holdings, Nitro Software Ltd, Kuaishou Technology, Chicony Electronics, CATL (A), Lenovo, Transcelestial Technologies and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Foreign Room Race for MSCI Re-Inclusion: SK Telecom Is Unexpectedly Rising
  • Alibaba: A Mediocre Beat Won’t Nullify Escalating US-China Tensions & A Deteriorating Core Business
  • Pushpay Holdings: ACC & Nikko Say No To Scheme
  • Nitro Software: KKR’s Offer Unconditional. This Is Potentia’s For The Taking
  • Pushpay (PPH NZ): Proxy Advisors Say Yes but Several Shareholders Say No
  • Kuaishou 4Q2022E Preview: Continued Recovery in Earnings
  • Quiddity TWSE Div+ Capping Flows March 2023: Final Minute Changes to Expectations
  • CATL Offering Steep Discounts to Automakers in Quid Pro Quo Deal, Source Says
  • Lenovo – Earnings Flash – Q3 FY 2022-23 Results – Lucror Analytics
  • Transcelestial Gets US$10M Funding Boost to Expand Its Lasercomms Tech into US, Ramp up in Asia

Foreign Room Race for MSCI Re-Inclusion: SK Telecom Is Unexpectedly Rising

By Sanghyun Park

  • Looking at the recent pattern, SKT’s fast-rising is quite noticeable. Its foreign room rose to 12.08%. On the other hand, KT’s foreign room growth seems to be slowing somewhat.
  • SKT’s pace is fast. If the current pace continues, there will be even the possibility of inclusion with a full adjustment factor of 1.0, exceeding 25%, by the August review. 
  • We should design a momentum trading setup targeting the point when SKT’s foreign room decline trend will be reflected into an MSCI re-inclusion momentum.

Alibaba: A Mediocre Beat Won’t Nullify Escalating US-China Tensions & A Deteriorating Core Business

By Oshadhi Kumarasiri

  • Alibaba Group (9988 HK)‘s 3QFY23 results scheduled to release this Thursday is yet again going to be somewhat disappointing with our analysis indicating around RMB35.0bn OP cf. RMB49.7bn in 3QFY21.
  • Nevertheless, 3QFY23 results could beat the conservative consensus revenue estimate by 2.8% while the OP is likely to be in line with consensus.
  • Having risen 100%+ in few months, a small beat is unlikely to drive-up the share price any longer. Renewed US-China tensions are likely going to be a much bigger driver.

Pushpay Holdings: ACC & Nikko Say No To Scheme

By David Blennerhassett

  • The Scheme Meeting for BGH/Sixth Street’s NZ$1.34/share Offer for church donor management play Pushpay Holdings (PPH NZ) will take place on the 3 March.
  • Accident Compensation Corporation (ACC), holding 6.2% of shares out, said it will vote against the Scheme. Nikko Asset Management (1.4%) also said they will reject the Offer. 
  • Shares have wobbled and are now 5.5% adrift of terms. BGH/Sixth Street still has the flexibility to bump.

Nitro Software: KKR’s Offer Unconditional. This Is Potentia’s For The Taking

By David Blennerhassett

  • Alludo has declared its Offer of A$2.15 cash per Nitro Software Ltd (NTO AU) share free from all remaining conditions.
  • Separately, Potentia’s due diligence is expected to conclude tomorrow, the 22 February, with the expectation it bumps its current offer of A$2.00/share.
  • Currently trading at A$2.20 per share suggesting limited upside from here. 

Pushpay (PPH NZ): Proxy Advisors Say Yes but Several Shareholders Say No

By Arun George

  • Shareholders representing around 12.6% of outstanding shares have stated that they will vote against Pushpay Holdings (PPH NZ)’s NZ$1.34 offer from Sixth Street/BGH (scheme vote on 3 March). 
  • The NO votes will need a less than 63% turnout to block the scheme. A 5% bump (NZ$1.41) would be in line with the IE’s valuation mid-point at current FX.
  • Sixth Street/BGH have taken issue with the IE’s valuation (unsuitable FX rates and optimistic forecasts) and have got proxy advisors’ support. Therefore, a bump is not a sure thing. 

Kuaishou 4Q2022E Preview: Continued Recovery in Earnings

By Shifara Samsudeen, ACMA, CGMA

  • Kuaishou Technology (1024 HK) will report 4Q2022 and full-year results on 23rd March 2023.
  • The company’s livestreaming revenues have made significant progress since 4Q2021 while its domestic business reported an operating profit for the first time in 3Q2022.
  • Though the company’s share price has not moved up yet, we think there is further upside to the current share price driven by improved earnings.

Quiddity TWSE Div+ Capping Flows March 2023: Final Minute Changes to Expectations

By Janaghan Jeyakumar, CFA

  • The index constituent weights of the TWSE Div+ Index will be capped during the upcoming March 2023 Index quarterly index review. 
  • Previously, it looked like there were going to be no flows. However, now my expectations have changed, as of Monday’s close (they weren’t going to change as of Friday).
  • In this insight, we take a look at Quiddity’s expectations for index flows resulting from these events. 

CATL Offering Steep Discounts to Automakers in Quid Pro Quo Deal, Source Says

By Caixin Global

  • Contemporary Amperex Technology Co. Ltd. (CATL), the world’s largest electric-vehicle (EV) battery-maker, is in talks to offer automakers steeply discounted prices in exchange for sourcing the vast bulk of their power cells from the company in a bid to stave off growing competition from smaller rivals, Caixin has learned.
  • If the plan goes ahead, CATL will sell the strategic clients EV batteries made from self-manufactured lithium carbonate at a low price.
  • In return, they will be required to sign a contract committing them to buy 80% of their EV batteries from CATL over the next three years, a person close to the company told Caixin on Sunday.

Lenovo – Earnings Flash – Q3 FY 2022-23 Results – Lucror Analytics

By Trung Nguyen

Lenovo has posted weak Q3/22-23 results. Revenue dropped 24% y-o-y to USD 15.3 bn, with gross profit down 22% at USD 2.6 bn and operating profit declining 20% to USD 750 mn. Net profit fell 32% to USD 437 mn. Positively, liquidity remains sound, with over USD 5 bn of cash and USD 20 bn of undrawn credit facilities. OCF stayed positive at USD 74 mn.


Transcelestial Gets US$10M Funding Boost to Expand Its Lasercomms Tech into US, Ramp up in Asia

By e27

  • Singapore-headquartered last-mile internet connectivity startup Transcelestial Technologies has received US$10 million in a Series A extension round.
  • Existing investor Airbus Ventures led the round, with participation from Kickstart Ventures, Genesis Alternative Ventures, Wavemaker, Cap Vista, and SEEDS Captial. In-Q-Tel had also joined in a previous undisclosed round.
  • The new round brings Transcelestial’s total investment raised to date to US$24 million.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Industrials: Jiangnan, Walsin Lihwa, TVS Supply Chain Solutions, Alfen and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Jiangnan Group (1366 HK): Chairman/CEO’s Privatisation Offer at HK$0.40
  • Quiddity TWSE 50 & 100 Mar 23 Final Expectations: There Could Be a Surprise Index Change!
  • TVS Supply Chain Solutions Pre-IPO – Profitability Might Have Been COVID-Driven
  • Quiddity Leaderboard SE600 Mar 23: Linde Deletion and 6 Regular ADDs/DELs
  • This Is Done. Chu’s Offer For Jiangnan (1366 HK)

Jiangnan Group (1366 HK): Chairman/CEO’s Privatisation Offer at HK$0.40

By Arun George

  • Jiangnan (1366 HK) disclosed a scheme privatisation offer from Mr Chu Hui (Chairman and CEO) at HK$0.40 per share, a 107.3% premium to the undisturbed price (HK$0.193 on 13 February).
  • The key condition is approval by at least 75% of disinterested shareholders (<10% of all disinterested shareholders rejection). The shareholder with a blocking stake will be supportive. 
  • The price is final and attractive in the context of historical prices and multiples. The scheme meeting is likely in mid-May. At last close, the gross spread is 12.7%.

Quiddity TWSE 50 & 100 Mar 23 Final Expectations: There Could Be a Surprise Index Change!

By Janaghan Jeyakumar, CFA

  • The reference period for the March 2023 index review for TWSE 50 and 100 indices just came to an end on 20 February.
  • Previously, it looked like there would not be any index changes during the March 2023 review for these two indices.
  • However, now it looks like there could be a change. 

TVS Supply Chain Solutions Pre-IPO – Profitability Might Have Been COVID-Driven

By Ethan Aw

  • TVS Supply Chain Solutions (1915741D IN) is looking to raise about US$500m in its upcoming India IPO.
  • TVS SCS is an Indian supply chain logistics solution provider which also has global capabilities and network across the value chain with cross deployment abilities, according to RedSeer. 
  • TVS SCS has seen its revenue grow as both its operating segments registered decent growth during the track record period. However, its profitability might have been a result of COVID-19. 

Quiddity Leaderboard SE600 Mar 23: Linde Deletion and 6 Regular ADDs/DELs

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the names leading the race to become ADDs/DELs for the STOXX Europe 600 and EURO STOXX Indices for the March 2023 Rebalance.
  • As it stands, I see 6 ADDs/DELs for the STOXX Europe 600 index and 3 ADDs and 2 DELs for the Euro STOXX Index in March 2023.
  • There are several names requiring a small price change to trigger more constituent changes and with few more days left to the reference date, a lot can change.

This Is Done. Chu’s Offer For Jiangnan (1366 HK)

By David Blennerhassett

  • After shares gained 63% in the morning session of the 16 Feb, then subsequently suspended, Chu Hui, the chairman and major shareholder, has made his move on Jiangnan (1366 HK).
  • Chu is offering HK$0.40/share by of a Scheme, a 12.68% premium to last close, but a whopping 83.49% over the last full trading day’s closing price. This price is final.
  • This is done. Expect payment around late July based on precedent Cayman-incorporated privatisations. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Energy/Materials: Origin Energy, New Century Resources, Agnico Eagle Mines and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Origin Energy (ORG AU): Recut Deal Is a Win-Win
  • Sibanye-Stillwater Raids New Century Resources (NCZ AU)
  • Agnico Eagle Mines – A record-breaking year

Origin Energy (ORG AU): Recut Deal Is a Win-Win

By Arun George

  • Origin Energy (ORG AU) has disclosed a revised non-binding proposal from Brookfield/EIG. The headline price has been lowered by -1.1% from A$9.00 to A$8.90 per share.
  • Under the revised proposal, shareholders’ first 100,000 shares get A$8.90. Beyond that ownership, the offer is A$4.334 plus US$3.194 per share (currently worth A$8.99 per share). 
  • While the recut introduces FX rate risk, the average implied value is A$9.01 since 10 November. Both the offeror and the Board seem keen to get a binding offer.

Sibanye-Stillwater Raids New Century Resources (NCZ AU)

By David Blennerhassett

  • Sibanye-Stillwater (SGL SJ), the holder of 19.9% of shares, has made an off-market takeover for Queensland zinc miner New Century Resources (NCZ AU) at $1.10/share, a 42.9% premium to last close.
  • Sibanye-Stillwater said it was concerned about the change in the strategic direction of NCZ under the current management.
  • Concurrently, Sibanye-Stillwater has made an on-market buy order for 10.92% (14.4mn shares) of shares out to take its stake to ~30%. Shares closed at $1.095. ~32mn shares changed hands.

Agnico Eagle Mines – A record-breaking year

By Edison Investment Research

FY22 marked a record-breaking year for Agnico Eagle Mines (AEM) after its Kirkland Lake acquisition, achieving annual gold production of 3,281koz at a US$780/oz total cash cost and a US$1,090/oz all-in sustaining cost (AISC). In Q422, AEM delivered strong gold production of 799koz at a US$863/oz cash cost, despite inflationary pressure and reduced production at LaRonde, Kittila and Pinos Altos. AEM’s quarterly dividend was maintained at US$0.40/share and it expects its recently announced acquisition of Yamana’s Canadian assets to close in March.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Financials: DGB Financial Group, FTSE China A50 Index, Draper Esprit and more

By | Daily Briefs, Financials

In today’s briefing:

  • KOSPI200 Index Rebalance Preview: Changes in April & June
  • A50 Sell Zone and SPX Color
  • Molten Ventures – Key takeaways from the 2023 capital markets day

KOSPI200 Index Rebalance Preview: Changes in April & June

By Brian Freitas


A50 Sell Zone and SPX Color

By Thomas Schroeder

  • A50 sell res near 14,100. Hard down close followed by 3% squeeze needs some digestion off of dual MA support. Our take is to sell strength.
  • HSI is trading heavy after a muted bounce with 19,600 targeted and remains our top short.
  • SPX needs a nudge and firm close below 4,080 to induce downside momentum and tip the global cycle.

Molten Ventures – Key takeaways from the 2023 capital markets day

By Edison Investment Research

At its capital markets day (CMD) Molten Ventures highlighted its successful growth since it listed in 2016, having grown its gross portfolio value by a CAGR of 59% (supported by several capital raises). We note that Molten posted a six-year NAV total return (TR) to end-September 2022 of c 15% pa. Since IPO, Molten has deployed an average £133m in capital per year (excluding secondary investments) and received £452m in total realisation proceeds. Portfolio growth has been underpinned by the 24% pa growth in European venture capital (VC) series A, B and C deal volumes (Molten’s ‘sweet spot’) between 2015 and 2022 (based on PitchBook data).


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Consumer: Jubilant Foodworks, Samyang Foods, Japan Tobacco, Tokyo Stock Exchange Tokyo Price Index Topix, Inter Parfums, General Mills, Kimberly Clark and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Jubilant Foodworks Vs Devyani International | When the Going Gets Tough
  • Samyang Foods: KOSPI 200 Inclusion & Improving Fundamentals
  • Japan Tobacco (2914) | Time to Work the Balance Sheet
  • Dissolving the Parent-Subsidiary Listing Is a Powerful Way to Increase Valuations?
  • IPAR: Fragrance of a Price Target Increase
  • General Mills: I Am Once Again Bullish And Have 2 Areas Investors Should Watch Closely
  • Kimberly-Clark: Short-Term Tailwinds Dissipate

Jubilant Foodworks Vs Devyani International | When the Going Gets Tough

By Pranav Bhavsar


Samyang Foods: KOSPI 200 Inclusion & Improving Fundamentals

By Douglas Kim

  • On 20 February, KRX announced that effective 13 April 2023, Samyang Foods will be included in the KOSPI 200 index and Hyundai Greenfood will be excluded.
  • We have a positive view on Samyang Foods and we believe this stock will outperform KOSPI leading into the week of KOSPI 200 inclusion (13 April). 
  • We think that expectation will play a bigger role and some investors may choose to buy this stock ahead of the actual inclusion date.

Japan Tobacco (2914) | Time to Work the Balance Sheet

By Mark Chadwick

  • The balance sheet is in great shape and could fund a much more aggressive growth strategy (or higher shareholder returns)
  • JT lags peers in the higher growth vape & oral markets. Ploom X needs investment to be a global hit. The balance sheet can easily fund both
  • Why bullish? The stock is trading cheap and offering a higher yield than its five-year average

Dissolving the Parent-Subsidiary Listing Is a Powerful Way to Increase Valuations?

By Aki Matsumoto

  • While this was a major step forward, it did not adequately explain how Fujitsu would invest the cash from the sale of these non-core businesses in its core businesses.
  • The investment strategy of buying listed subsidiaries with parent-subsidiary listings was shown to be reasonable. The exit risk may be lower when the parent makes the subsidiary a wholly-owned subsidiary.
  • If valuations are enhanced by expectations of increased corporate value through reviews of the parent’s business portfolio, the dissolution of the parent-subsidiary listing is a powerful way to enhance valuations.

IPAR: Fragrance of a Price Target Increase

By Hamed Khorsand

  • Since our last update in January 2023, Inter Parfums (IPAR) has released its preliminary fourth quarter sales results and there has been more data affirming consumer demand for fragrances
  • The reopening of China was earlier than IPAR’s management’s forecasts, which could have a material boost to sales in 2023.
  • The addition of Lacoste to the product portfolio remains the catalyst for 2024 sales growth

General Mills: I Am Once Again Bullish And Have 2 Areas Investors Should Watch Closely

By Vladimir Dimitrov, CFA

  • General Mills continued to outperform the market, in spite of the sharp drop in share price in recent months.
  • The company now trades closer to fair value, but weakness in the pet food segment was largely unexpected.
  • The drop in volumes is unsettling, but the company now trading closer to a fair value.

Kimberly-Clark: Short-Term Tailwinds Dissipate

By Vladimir Dimitrov, CFA

  • Kimberly-Clark’s stock has enjoyed a brief period of at-par performance with the rest of the equity market.
  • Some of the tailwinds that made this rally possible are dissipating and are unlikely to provide a sustainable tailwind for shareholders.
  • In recent years, it has been next to impossible to conceive a long investment thesis for Kimberly-Clark (NYSE:KMB).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Private Markets: Transcelestial Gets US$10M Funding Boost to Expand Its Lasercomms Tech into US and more

By | Daily Briefs, Private Markets

In today’s briefing:

  • Transcelestial Gets US$10M Funding Boost to Expand Its Lasercomms Tech into US, Ramp up in Asia

Transcelestial Gets US$10M Funding Boost to Expand Its Lasercomms Tech into US, Ramp up in Asia

By e27

  • Singapore-headquartered last-mile internet connectivity startup Transcelestial Technologies has received US$10 million in a Series A extension round.
  • Existing investor Airbus Ventures led the round, with participation from Kickstart Ventures, Genesis Alternative Ventures, Wavemaker, Cap Vista, and SEEDS Captial. In-Q-Tel had also joined in a previous undisclosed round.
  • The new round brings Transcelestial’s total investment raised to date to US$24 million.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ESG: Dissolving the Parent-Subsidiary Listing Is a Powerful Way to Increase Valuations? and more

By | Daily Briefs, ESG

In today’s briefing:

  • Dissolving the Parent-Subsidiary Listing Is a Powerful Way to Increase Valuations?

Dissolving the Parent-Subsidiary Listing Is a Powerful Way to Increase Valuations?

By Aki Matsumoto

  • While this was a major step forward, it did not adequately explain how Fujitsu would invest the cash from the sale of these non-core businesses in its core businesses.
  • The investment strategy of buying listed subsidiaries with parent-subsidiary listings was shown to be reasonable. The exit risk may be lower when the parent makes the subsidiary a wholly-owned subsidiary.
  • If valuations are enhanced by expectations of increased corporate value through reviews of the parent’s business portfolio, the dissolution of the parent-subsidiary listing is a powerful way to enhance valuations.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars